DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Jun 2022
DUOPHARMA BIOTECH BERHAD |
Financial Year End | 31 Dec 2022 |
Quarter | 2 Qtr |
Quarterly report for the financial period ended | 30 Jun 2022 |
The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
30 Jun 2022
|
30 Jun 2021
|
30 Jun 2022
|
30 Jun 2021
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
181,742
|
155,439
|
367,683
|
321,893
|
2 | Profit/(loss) before tax |
21,473
|
20,197
|
48,119
|
43,373
|
3 | Profit/(loss) for the period |
16,311
|
15,390
|
36,602
|
33,004
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
16,311
|
15,390
|
36,602
|
33,004
|
5 | Basic earnings/(loss) per share (Subunit) |
1.72
|
1.63
|
3.88
|
3.51
|
6 | Proposed/Declared dividend per share (Subunit) |
0.50
|
0.50
|
0.50
|
0.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.6700
|
0.6600
|
Remarks : |
Pursuant to MFRS 133, Earnings Per Share for the corresponding quarter and year to date ended 30 June 2021 had been retrospectively adjusted to reflect the effect of the bonus shares allotted on 7 September 2021. |
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | DUOPHARMA BIOTECH BERHAD |
Stock Name | DPHARMA |
Date Announced | 16 Aug 2022 |
Category | Financial Results |
Reference Number | FRA-29072022-00006 |